Ameriprise’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-97,000
Closed -$18M 4153
2025
Q3
$18M Buy
+97,000
New +$16.6M ﹤0.01% 1478

Other funds holding JNJ

Ameriprise's JNJ Position: Q1 2026 in Review

Ameriprise increased its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, buying an estimated $77.6M and bringing the position to 13,779,406 shares worth $3.37B. The position accounts for 0.78% of the portfolio, ranked #14.

Ameriprise first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.71B in Q1 2022. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ameriprise held 13,779,406 shares of Johnson & Johnson worth $3.37B as of Q1 2026.
  • Ameriprise bought 332,966 Johnson & Johnson shares in Q1 2026, an estimated $77.6M.
  • Johnson & Johnson made up 0.78% of Ameriprise's portfolio in Q1 2026, its #14 holding.
  • Ameriprise first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Johnson & Johnson position peaked at $3.71B in Q1 2022.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.